ELL C-terminal region polyclonal, anti-human, mour, rat, zebrafish, dog, guinea pig, horse, bovine

Background:
This is a rabbit polyclonal antibody against ELL. It was validated on Western Blot and immunohistochemistry by Abgent. At Abgent we manufacture rabbit polyclonal antibodies on a large scale (200-1000 products/month) of high throughput manner. Our antibodies are peptide based and protein family oriented. We usually provide antibodies covering each member of a whole protein family of your interest. We also use our best efforts to provide you antibodies recognize various epitopes of a target protein.

Other Names:
RNA polymerase II elongation factor ELL, Eleven-nineteen lysine-rich leukemia protein, ELL, C19orf17

Target/Specificity:
ELL was shown to encode a previously uncharacterized elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by polymerase at multiple sites along the DNA. Functionally, ELL resembles Elongin (SIII), a transcription elongation factor regulated by the product of the von Hippel-Lindau (VHL) tumor suppressor gene.

Immunogen:
The immunogen for anti-ELL antibody: synthetic peptide directed towards the C terminal of human ELL

Gene Name:
ELL
Gene Name:
8178
Swissprot ID: P55199
NCBI Accession:
NP_006523
Primary Accession: P55199
Other Accession: P55199;NP_006523;NM_006532
Purification: Protein A purified
Format: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.